Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving.

Blackwood CA, Leary M, Salisbury A, McCoy MT, Cadet JL.

Neuroscience. 2019 Jul 24;415:173-183. doi: 10.1016/j.neuroscience.2019.07.030. [Epub ahead of print]

PMID:
31351142
2.

A Method for Improving the Accuracy and Efficiency of Bacteriophage Genome Annotation.

Salisbury A, Tsourkas PK.

Int J Mol Sci. 2019 Jul 10;20(14). pii: E3391. doi: 10.3390/ijms20143391.

3.

A Detailed Analysis of Perforations During Chronic Total Occlusion Angioplasty.

Hirai T, Nicholson WJ, Sapontis J, Salisbury AC, Marso SP, Lombardi W, Karmpaliotis D, Moses J, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Nugent K, Gosch KL, Spertus JA, Grantham JA; OPEN-CTO Study Group.

JACC Cardiovasc Interv. 2019 Jun 19. pii: S1936-8798(19)31164-1. doi: 10.1016/j.jcin.2019.05.024. [Epub ahead of print]

PMID:
31255554
4.

Evaluating the ability of citizen scientists to identify bumblebee (Bombus) species.

Falk S, Foster G, Comont R, Conroy J, Bostock H, Salisbury A, Kilbey D, Bennett J, Smith B.

PLoS One. 2019 Jun 24;14(6):e0218614. doi: 10.1371/journal.pone.0218614. eCollection 2019.

5.

Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.

Bhardwaj B, Spertus JA, Kennedy KF, Jones WS, Safley D, Tsai TT, Aronow HD, Vora AN, Pokharel Y, Kumar A, Attaran RR, Feldman DN, Armstrong E, Prasad A, Gray B, Salisbury AC.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1140-1149. doi: 10.1016/j.jcin.2019.03.012.

PMID:
31221303
6.

Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.

Hirai T, Qintar M, Grantham JA, Sapontis J, Cohen DJ, Lombardi W, Karmpaliotis D, Moses J, Nicholson WJ, Nugent K, Gosch KL, Spertus JA, Salisbury AC.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005287. doi: 10.1161/CIRCOUTCOMES.118.005287. Epub 2019 Jun 12.

PMID:
31185735
7.

De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.

Qintar M, Hirai T, Arnold SV, Sheehy J, Sapontis J, Jones P, Tang Y, Lombardi W, Karmpaliotis D, Moses J, Patterson C, Nicholson WJ, Cohen DJ, Spertus JA, Grantham JA, Salisbury AC.

Am Heart J. 2019 Aug;214:1-8. doi: 10.1016/j.ahj.2019.04.013. Epub 2019 Apr 26.

PMID:
31152872
8.

Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status.

Peri-Okonny PA, Spertus JA, Grantham JA, Gosch K, Kirtane A, Sapontis J, Lombardi W, Karmpaliotis D, Moses J, Nicholson W, Salisbury AC.

J Am Heart Assoc. 2019 Apr 2;8(7):e011629. doi: 10.1161/JAHA.118.011629.

9.

In vitro cellular viability studies on a concentrated surfactant-based wound dressing.

Chen R, Salisbury AM, Percival SL.

Int Wound J. 2019 Jun;16(3):703-712. doi: 10.1111/iwj.13084. Epub 2019 Mar 20.

PMID:
30895731
10.

Anti-Anginal Medication Titration Among Patients with Residual Angina 6-Months After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from OPEN CTO Registry.

Sheehy JP, Qintar M, Arnold SV, Hirai T, Sapontis J, Jones PG, Tang Y, Lombardi W, Karmpaliotis D, Moses JW, Patterson C, Cohen DJ, Amin AP, Nicholson WJ, Spertus JA, Grantham JA, Salisbury AC.

Eur Heart J Qual Care Clin Outcomes. 2019 Mar 21. pii: qcz015. doi: 10.1093/ehjqcco/qcz015. [Epub ahead of print]

PMID:
30895291
11.

Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina.

Hirai T, Grantham JA, Sapontis J, Cohen DJ, Marso SP, Lombardi W, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Nugent K, Gosch KL, Spertus JA, Salisbury AC.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007558. doi: 10.1161/CIRCINTERVENTIONS.118.007558.

PMID:
30871356
12.

Silver, biofilms and wounds: resistance revisited.

Percival SL, Salisbury AM, Chen R.

Crit Rev Microbiol. 2019 Mar;45(2):223-237. doi: 10.1080/1040841X.2019.1573803. Epub 2019 Feb 22.

PMID:
30794043
13.

Complete Genome Sequences of Mycobacterium smegmatis Phages Chewbacca, Reptar3000, and Riparian, Isolated in Las Vegas, Nevada.

Salisbury A, Cassin E, Ayala-Pineda K, Barroga N, Cadiz V, Cisneros R, Fersini J, Jeanite T, Juste J, Ines J, Leyva G, Macalinao D, Muscelli S, Nhan S, Reyes GS, Rhoden H, Tan R, Torres E, Tran K, Uriarte-Valle G, Wallace C, Wong S, Regner K, Strong C, Tsourkas PK.

Microbiol Resour Announc. 2019 Feb 7;8(6). pii: e01558-18. doi: 10.1128/MRA.01558-18. eCollection 2019 Feb.

14.

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.

Salisbury AC, Karmpaliotis D, Grantham JA, Sapontis J, Meng Q, Magnuson EA, Gada H, Lombardi W, Moses J, Li H, Arnold SV, Baron SJ, Spertus JA, Cohen DJ.

JACC Cardiovasc Interv. 2019 Feb 25;12(4):323-331. doi: 10.1016/j.jcin.2018.10.025. Epub 2019 Jan 30.

PMID:
30711549
15.

Complete Genome Sequences of 18 Paenibacillus larvae Phages from the Western United States.

Merrill BD, Fajardo CP, Hilton JA, Payne AM, Ward AT, Walker JK, Dhalai A, Imahara C, Mangohig J, Monk J, Pascacio C, Rai P, Salisbury A, Velez K, Bloomfield TJ, Buhler B, Duncan SG, Fuhriman DA, George J, Graves K, Heaton K, Hill HL, Kim M, Knabe BK, Ririe DB, Rogers SL, Stamereilers C, Stephenson MB, Usher BK, Ward CS, Withers JM, Wright CK, Breakwell DP, Grose JH, Hope S, Tsourkas PK.

Microbiol Resour Announc. 2018 Oct 4;7(13). pii: e00966-18. doi: 10.1128/MRA.00966-18. eCollection 2018 Oct.

16.

Complete Genome Sequences of Paenibacillus larvae Phages Halcyone, Heath, Scottie, and Unity from Las Vegas, Nevada.

Yost DG, Chang C, LeBlanc L, Cassin E, Peterman C, Rai P, Salisbury A, Barroga N, Cisneros R, Fersini J, Juste J, Ines J, Leyva G, Macalinao D, Muscelli S, Reyes GS, Rhoden H, Tan R, Torres E, Tran K, Uriarte-Valle G, Wallace C, Wong S, Ayala-Pineda K, Cadiz V, Jeanite T, Nhan S, Grose JH, Strong C, Amy PS, Tsourkas PK.

Microbiol Resour Announc. 2018 Sep 27;7(12). pii: e00977-18. doi: 10.1128/MRA.00977-18. eCollection 2018 Sep.

17.

Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

Khariton Y, Airhart S, Salisbury AC, Spertus JA, Gosch KL, Grantham JA, Karmpaliotis D, Moses JW, Nicholson WJ, Cohen DJ, Lombardi W, Sapontis J, McCabe JM.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2276-2283. doi: 10.1016/j.jcin.2018.07.058.

18.

Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: Experience from a high-volume referral center.

Goleski PJ, Nakamura K, Liebeskind E, Salisbury AC, Grantham JA, McCabe JM, Lombardi WL.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):191-198. doi: 10.1002/ccd.27783. Epub 2018 Nov 9.

PMID:
30411863
19.

Efficacy of a Surfactant-Based Wound Dressing in the Prevention of Biofilms.

Salisbury AM, Percival SL.

Adv Skin Wound Care. 2018 Nov;31(11):514-520. doi: 10.1097/01.ASW.0000544612.28804.34.

PMID:
30335643
20.

Tolerance of Biofilms to Antimicrobials and Significance to Antibiotic Resistance in Wounds.

Salisbury AM, Woo K, Sarkar S, Schultz G, Malone M, Mayer DO, Percival SL.

Surg Technol Int. 2018 Nov 11;33:59-66. Review.

PMID:
30326137
21.

Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes.

Amin AP, Pinto D, House JA, Rao SV, Spertus JA, Cohen MG, Pancholy S, Salisbury AC, Mamas MA, Frogge N, Singh J, Lasala J, Masoudi FA, Bradley SM, Wasfy JH, Maddox TM, Kulkarni H.

JAMA Cardiol. 2018 Nov 1;3(11):1041-1049. doi: 10.1001/jamacardio.2018.3029.

22.

Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.

Stroud LR, Papandonatos GD, McCallum M, Kehoe T, Salisbury AL, Huestis MA.

Neurotoxicol Teratol. 2018 Nov - Dec;70:28-39. doi: 10.1016/j.ntt.2018.09.003. Epub 2018 Sep 26.

PMID:
30266574
23.

Efficacy of Concentrated Surfactant-Based Wound Dressings in Wound Repair and Biofilm Reduction.

Salisbury AM, Mayer D, Chen R, Percival SL.

Adv Wound Care (New Rochelle). 2018 Sep 1;7(9):315-322. doi: 10.1089/wound.2017.0782. Epub 2018 Sep 4.

PMID:
30263875
24.

Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.

McGarry DH, Cooper IR, Walker R, Warrilow CE, Pichowicz M, Ratcliffe AJ, Salisbury AM, Savage VJ, Moyo E, Maclean J, Smith A, Charrier C, Stokes NR, Lindsay DM, Kerr WJ.

Bioorg Med Chem Lett. 2018 Sep 15;28(17):2998-3003. doi: 10.1016/j.bmcl.2018.05.049. Epub 2018 May 26.

PMID:
30122228
25.

Impact of maternal prenatal smoking on fetal to infant neurobehavioral development.

Stroud LR, McCallum M, Salisbury AL.

Dev Psychopathol. 2018 Aug;30(3):1087-1105. doi: 10.1017/S0954579418000676.

26.

Maintenance of photosynthesis by Betula populifolia in metal contaminated soils.

Salisbury AB, Gallagher FJ, Caplan JS, Grabosky JC.

Sci Total Environ. 2018 Jun 1;625:1615-1627. doi: 10.1016/j.scitotenv.2017.12.279. Epub 2018 Jan 13.

PMID:
29996458
27.

Complete Genome Sequences of Paenibacillus larvae Phages BN12, Dragolir, Kiel007, Leyra, Likha, Pagassa, PBL1c, and Tadhana.

Walker JK, Merrill BD, Berg JA, Dhalai A, Dingman DW, Fajardo CP, Graves K, Hill HL, Hilton JA, Imahara C, Knabe BK, Mangohig J, Monk J, Mun H, Payne AM, Salisbury A, Stamereilers C, Velez K, Ward AT, Breakwell DP, Grose JH, Hope S, Tsourkas PK.

Genome Announc. 2018 Jun 14;6(24). pii: e01602-17. doi: 10.1128/genomeA.01602-17.

28.

Mode of action of poloxamer-based surfactants in wound care and efficacy on biofilms.

Percival SL, Chen R, Mayer D, Salisbury AM.

Int Wound J. 2018 Oct;15(5):749-755. doi: 10.1111/iwj.12922. Epub 2018 Jun 5.

PMID:
29869367
29.

Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers.

Percival SL, Malone M, Mayer D, Salisbury AM, Schultz G.

Int Wound J. 2018 Oct;15(5):776-782. doi: 10.1111/iwj.12926. Epub 2018 Jun 4. Review.

PMID:
29863794
30.

The Efficacy of an Electrolysed Water Formulation on Biofilms.

Salisbury AM, Percival SL.

Adv Exp Med Biol. 2018 May 11. doi: 10.1007/5584_2018_207. [Epub ahead of print]

PMID:
29748921
31.

Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.

Kaltenbach K, O'Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, Martin PR, Stine S, Jones HE.

Drug Alcohol Depend. 2018 Apr 1;185:40-49. doi: 10.1016/j.drugalcdep.2017.11.030. Epub 2018 Feb 1.

32.

Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions: The CrossBoss First Trial.

Karacsonyi J, Tajti P, Rangan BV, Halligan SC, Allen RH, Nicholson WJ, Harvey JE, Spaedy AJ, Jaffer FA, Grantham JA, Salisbury A, Hart AJ, Safley DM, Lombardi WL, Hira R, Don C, McCabe JM, Burke MN, Alaswad K, Koenig GC, Sanghvi KA, Ice D, Kovach RC, Varghese V, Murad B, Baran KW, Resendes E, Martinez-Parachini JR, Karatasakis A, Danek BA, Iwnetu R, Roesle M, Khalili H, Banerjee S, Brilakis ES.

JACC Cardiovasc Interv. 2018 Feb 12;11(3):225-233. doi: 10.1016/j.jcin.2017.10.023.

33.

Association of Stress Test Risk Classification With Health Status After Chronic Total Occlusion Angioplasty (from the Outcomes, Patient Health Status and Efficiency in Chronic Total Occlusion Hybrid Procedures [OPEN-CTO] Study).

Salisbury AC, Sapontis J, Saxon JT, Gosch KL, Lombardi WL, Karmpaliotis D, Moses JW, Qintar M, Kirtane AJ, Spertus JA, Cohen DJ, Grantham JA.

Am J Cardiol. 2018 Mar 1;121(5):558-563. doi: 10.1016/j.amjcard.2017.11.024. Epub 2017 Dec 11.

PMID:
29289358
34.

The Efficacy of Tetrasodium EDTA on Biofilms.

Percival SL, Salisbury AM.

Adv Exp Med Biol. 2018;1057:101-110. doi: 10.1007/5584_2017_134.

PMID:
29280095
35.

Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.

Thompson LE, Masoudi FA, Gosch KL, Peterson PN, Jones PG, Salisbury AC, Kosiborod M, Daugherty SL.

Clin Cardiol. 2017 Dec;40(12):1279-1284. doi: 10.1002/clc.22824. Epub 2017 Dec 16.

36.

Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.

Qintar M, Grantham JA, Sapontis J, Gosch KL, Lombardi W, Karmpaliotis D, Moses J, Salisbury AC, Cohen DJ, Spertus JA, Arnold SV.

Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12). pii: e003665. doi: 10.1161/CIRCOUTCOMES.117.003665.

37.

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes: Insights From the OPEN CTO Registry.

Salisbury AC, Sapontis J, Grantham JA, Qintar M, Gosch KL, Lombardi W, Karmpaliotis D, Moses J, Cohen DJ, Spertus JA, Kosiborod M; OPEN CTO Study Group.

JACC Cardiovasc Interv. 2017 Nov 13;10(21):2174-2181. doi: 10.1016/j.jcin.2017.08.043.

38.

Impact of subintimal plaque modification procedures on health status after unsuccessful chronic total occlusion angioplasty.

Hirai T, Grantham JA, Sapontis J, Cohen DJ, Marso SP, Lombardi W, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Nugent K, Gosch KL, Spertus JA, Salisbury AC; OPEN CTO Study Group.

Catheter Cardiovasc Interv. 2018 May 1;91(6):1035-1042. doi: 10.1002/ccd.27380. Epub 2017 Oct 25.

PMID:
29068126
39.

The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention.

Qintar M, Towheed A, Tang F, Salisbury AC, Ho PM, Grantham JA, Spertus JA, Arnold SV.

J Am Heart Assoc. 2017 Oct 20;6(10). pii: e006405. doi: 10.1161/JAHA.117.006405.

40.

Health status outcomes of percutaneous coronary intervention in bypass grafts vs. native coronary arteries.

Qintar M, Omer M, Tang F, Arnold SV, Spertus JA, Salisbury AC.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):160-161. doi: 10.1093/ehjqcco/qcw053. No abstract available.

41.

Efficacy of a surfactant-based wound dressing on biofilm control.

Percival SL, Mayer D, Salisbury AM.

Wound Repair Regen. 2017 Sep;25(5):767-773. doi: 10.1111/wrr.12581. Epub 2017 Oct 11.

PMID:
28857343
42.

Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures).

Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, McCabe JM, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Thompson CR, Marso SP, Nugent K, Gosch K, Spertus JA, Grantham JA.

JACC Cardiovasc Interv. 2017 Aug 14;10(15):1523-1534. doi: 10.1016/j.jcin.2017.05.065.

43.

In-Hospital Outcomes of Percutaneous Coronary Intervention in America's Safety Net: Insights From the NCDR Cath-PCI Registry.

Acharya T, Salisbury AC, Spertus JA, Kennedy KF, Bhullar A, Reddy HKK, Joshi BK, Ambrose JA.

JACC Cardiovasc Interv. 2017 Aug 14;10(15):1475-1485. doi: 10.1016/j.jcin.2017.05.042.

44.

Polar Organizing Protein PopZ Is Required for Chromosome Segregation in Agrobacterium tumefaciens.

Ehrle HM, Guidry JT, Iacovetto R, Salisbury AK, Sandidge DJ, Bowman GR.

J Bacteriol. 2017 Aug 8;199(17). pii: e00111-17. doi: 10.1128/JB.00111-17. Print 2017 Sep 1.

45.

Absence of the Polar Organizing Protein PopZ Results in Reduced and Asymmetric Cell Division in Agrobacterium tumefaciens.

Howell M, Aliashkevich A, Salisbury AK, Cava F, Bowman GR, Brown PJB.

J Bacteriol. 2017 Aug 8;199(17). pii: e00101-17. doi: 10.1128/JB.00101-17. Print 2017 Sep 1.

46.

Pregnancy and postpartum antidepressant use moderates the effects of sleep on depression.

Stone KC, Salisbury AL, Miller-Loncar CL, Mattera JA, Battle CL, Johnsen DM, O'Grady KE.

Arch Womens Ment Health. 2017 Oct;20(5):621-632. doi: 10.1007/s00737-017-0726-9. Epub 2017 May 9.

PMID:
28488099
47.

Noncardiac chest pain after acute myocardial infarction: Frequency and association with health status outcomes.

Qintar M, Spertus JA, Tang Y, Buchanan DM, Chan PS, Amin AP, Salisbury AC.

Am Heart J. 2017 Apr;186:1-11. doi: 10.1016/j.ahj.2017.01.001. Epub 2017 Jan 5.

48.

Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.

Shafiq A, Gosch K, Amin AP, Ting HH, Spertus JA, Salisbury AC.

Clin Cardiol. 2017 Aug;40(8):521-527. doi: 10.1002/clc.22693. Epub 2017 Mar 16.

49.

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

Charrier C, Salisbury AM, Savage VJ, Duffy T, Moyo E, Chaffer-Malam N, Ooi N, Newman R, Cheung J, Metzger R, McGarry D, Pichowicz M, Sigerson R, Cooper IR, Nelson G, Butler HS, Craighead M, Ratcliffe AJ, Best SA, Stokes NR.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02100-16. doi: 10.1128/AAC.02100-16. Print 2017 May.

50.

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.

Salisbury AC, Li H, Vilain KR, Jaff MR, Schneider PA, Laird JR, Cohen DJ.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2343-2352. doi: 10.1016/j.jcin.2016.08.036.

Supplemental Content

Loading ...
Support Center